U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07752966) titled 'Evaluation of a Genetic Risk Score for Lung Metastasis and Prognosis in Breast Cancer' on Aug. 02.
Brief Summary: The goal of this observational study is to validate the predictive ability of a six-gene risk score model for lung metastasis in patients with early-stage breast cancer.
The main questions it aims to answer are:
Does the gene risk score accurately identify patients at high risk of developing lung metastases? Does it predict lung metastasis-free survival and overall survival in these patients? How does its performance compare with traditional clinical indicators (such as TNM stage, molecular subtype, and Ki-67) across di...